Status:
COMPLETED
Transplant and Addiction Project (TAP) - 1
Lead Sponsor:
St. Luke's-Roosevelt Hospital Center
Conditions:
End Stage Liver Disease
End Stage Renal Disease
Eligibility:
All Genders
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
The purpose of this study is to test a novel distance-based (telephone) intervention to help transplant candidates with current or recent substance abuse to stay "clean and sober" both prior and follo...
Detailed Description
Participants who need a liver or renal transplant and who are ineligible due to current or recent (past 6 months) alcohol and/or other drug abuse are being recruited from the transplant programs at St...
Eligibility Criteria
Inclusion
- End stage liver or renal disease
- Having used drugs or alcohol during the past 6 months
- Turned down for transplant due to current or recent substance use
- Access to telephone
Exclusion
- Psychotic or other unstable serious psychiatric disorders that preclude full, active participation
- Moderate to severe hepatic encephalopathy
- Non-English speaking
Key Trial Info
Start Date :
September 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2009
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT00249652
Start Date
September 1 2003
End Date
September 1 2009
Last Update
April 14 2015
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Behavioral Science Research Unit
New York, New York, United States, 10025
2
Renal & Islet Transplant, Center for Liver Disease
New York, New York, United States, 10032
3
Liver Transplant Program
Richmond, Virginia, United States, 23298